1 Sperimentazioni cliniche internazionali ;
-
- GERMANIA
- Bayern
- REGENSBURG
- SAPPHIRE : Efficacy and safety of AP 12009 (Trabedersen) in adult patients with recurrent or refractory Anaplastic Astrocytoma (WHO grade III) as compared to standard treatment with Temozolomide or BCNU : a randomized, actively controlled, open-label Phase III Study (coordination)
- Antisense Pharma GmbH
- Ulteriori informazioni